Arg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans

Prostaglandins and Other Lipid Mediators

Volumn 113-115, Issue , 2014, Pages 38-44

  Ramirez, Claudia E ^a   Shuey, Megan M ^a   Milne, Ginger L ^a   Gilbert, Kimberly ^a   Hui, Nian ^a   Yu, Chang ^a   Luther, James M ^a   Brown, Nancy J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epoxyeicosatrienoic acids; Insulin sensitivity; Metabolic syndrome; Soluble epoxide hydrolase

Indexed keywords

ARGININE; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; GLUTAMINE; LYSINE; ARACHIDONIC ACID DERIVATIVE; DNA; EPHX2 PROTEIN, HUMAN; INSULIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; EPHX2 GENE; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHENOTYPE; BLOOD; CHEMISTRY; GENETICS; GLUCOSE CLAMP TECHNIQUE; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SECRETION (PROCESS); YOUNG ADULT;

ADULT; ARACHIDONIC ACIDS; BODY MASS INDEX; DNA; EPOXIDE HYDROLASES; FEMALE; GENETIC VARIATION; GENOTYPE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84909993389     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2014.08.001     Document Type: Article

References (29)

1. D.R. Whiting, L. Guariguata, C. Weil, and J. Shaw IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 Diabetes Res Clin Pract 94 2011 311 321
2. S.E. Kahn, R.L. Hull, and K.M. Utzschneider Mechanisms linking obesity to insulin resistance and type 2 diabetes Nature 444 2006 840 846
3. A. Luria, A. Bettaieb, Y. Xi, G.J. Shieh, H.C. Liu, and H. Inoue Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance Proc Natl Acad Sci U S A 108 2011 9038 9043
4. J. Capdevila, N. Chacos, J. Werringloer, R.A. Prough, and R.W. Estabrook Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid Proc Natl Acad Sci U S A. 78 1981 5362 5366
5. J.H. Capdevila, S. Wei, A. Kumar, J. Kobayashi, J.R. Snapper, and D.C. Zeldin Resolution of dihydroxyeicosanoates and of dihydroxyeicosatrienoates by chiral phase chromatography Anal Biochem 207 1992 236 240
6. D. Gebremedhin, Y.H. Ma, J.R. Falck, R.J. Roman, M. VanRollins, and D.R. Harder Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle Am J Physiol 263 1992 H519 H525
7. K. Node, Y. Huo, X. Ruan, B. Yang, M. Spiecker, and K. Ley Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids Science 285 1999 1276 1279
8. Y. Sakairi, H.R. Jacobson, T.D. Noland, J.H. Capdevila, J.R. Falck, and M.D. Breyer 5,6-EET inhibits ion transport in collecting duct by stimulating endogenous prostaglandin synthesis Am J Physiol 268 1995 F931 F939
9. J.K. Beetham, T. Tian, and B.D. Hammock cDNA cloning and expression of a soluble epoxide hydrolase from human liver Arch Biochem Biophys 305 1993 197 201
10. C. Larsson, I. White, C. Johansson, A. Stark, and J. Meijer Localization of the human soluble epoxide hydrolase gene (EPHX2) to chromosomal region 8p21-p12 Hum Genet 95 1995 356 358
11. X. Zhao, A. Dey, O.P. Romanko, D.W. Stepp, M.H. Wang, and Y. Zhou Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats Am J Physiol Regul Integr Comp Physiol 288 2005 R188 R196
12. B.M. De Taeye, C. Morisseau, J. Coyle, J.W. Covington, A. Luria, and J. Yang Expression and regulation of soluble epoxide hydrolase in adipose tissue Obesity (Silver Spring) 18 2010 489 498
13. A. Iyer, K. Kauter, M.A. Alam, S.H. Hwang, C. Morisseau, and B.D. Hammock Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats Exp Diabetes Res 2012 2012 758614
14. A. Bettaieb, N. Nagata, D. AbouBechara, S. Chahed, C. Morisseau, and B.D. Hammock Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue J Biol Chem 288 2013 14189 14199
15. P. Luo, H.H. Chang, Y. Zhou, S. Zhang, S.H. Hwang, and C. Morisseau Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis J Pharmacol Exp Ther 334 2010 430 438
16. B.D. Przybyla-Zawislak, P.K. Srivastava, J. Vazquez-Matias, H.W. Mohrenweiser, J.E. Maxwell, and B.D. Hammock Polymorphisms in human soluble epoxide hydrolase Mol Pharmacol 64 2003 482 490
17. C.R. Lee, M. Pretorius, R.N. Schuck, L.H. Burch, J. Bartlett, and S.M. Williams Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans Hypertension 57 2011 116 122
18. R.A. DeFronzo, J.D. Tobin, and R. Andres Glucose clamp technique: a method for quantifying insulin secretion and resistance Am J Physiol 237 1979 E214 E223
19. J.W. Newman, T. Watanabe, and B.D. Hammock The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS J Lipid Res 43 2002 1563 1578
20. A. Luria, S.M. Weldon, A.K. Kabcenell, R.H. Ingraham, D. Matera, and H. Jiang Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice J Biol Chem 282 2007 2891 2898
21. R: A Language and Environment for Statistical Computing 2014 Foundation for Statistical Computing Vienna, Austria http://R-project.org/
22. H.O. Steinberg, H. Chaker, R. Leaming, A. Johnson, G. Brechtel, and A.D. Baron Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance J Clin Invest 97 1996 2601 2610
23. A.D. Baron, H.O. Steinberg, H. Chaker, R. Leaming, A. Johnson, and G. Brechtel Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans J Clin Invest 96 1995 786 792
24. J.M. Lizcano, and D.R. Alessi The insulin signalling pathway Curr Biol 12 2002 R236 R238
25. J.R. Falck, S. Manna, J. Moltz, N. Chacos, and J. Capdevila Epoxyeicosatrienoic acids stimulate glucagon and insulin release from isolated rat pancreatic islets Biochem Biophys Res Commun 114 1983 743 749
26. E.L. Klett, S. Chen, M.L. Edin, L.O. Li, O. Ilkayeva, and D.C. Zeldin Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion J Biol Chem 288 2013 21618 21629
27. K.N. Theken, R.N. Schuck, M.L. Edin, B. Tran, K. Ellis, and A. Bass Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease Atherosclerosis 222 2012 530 536
28. B.B. Kahn, and J.S. Flier Obesity and insulin resistance J Clin Invest 106 2000 473 481
29. K. Ohtoshi, H. Kaneto, K. Node, Y. Nakamura, T. Shiraiwa, and M. Matsuhisa Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients Biochem Biophys Res Commun 331 2005 347 350